# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-21-037501
Filing Date
2021-11-12
Accepted
2021-11-12 06:05:31
Documents
43
Period of Report
2021-11-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | brhc10030727_8k.htm iXBRL | 8-K | 28851
2 | EXHIBIT 99.1 | brhc10030727_ex99-1.htm | EX-99.1 | 47941
6 |  | brhc10030727_ex99-1slide31.jpg | GRAPHIC | 61427
7 |  | brhc10030727_ex99-1slide32.jpg | GRAPHIC | 340198
8 |  | brhc10030727_ex99-1slide33.jpg | GRAPHIC | 211615
9 |  | brhc10030727_ex99-1slide34.jpg | GRAPHIC | 79008
10 |  | brhc10030727_ex99-1slide35.jpg | GRAPHIC | 126096
11 |  | brhc10030727_ex99-1slide36.jpg | GRAPHIC | 91596
12 |  | brhc10030727_ex99-1slide37.jpg | GRAPHIC | 90297
13 |  | brhc10030727_ex99-1slide38.jpg | GRAPHIC | 117459
14 |  | brhc10030727_ex99-1slide39.jpg | GRAPHIC | 139156
15 |  | brhc10030727_ex99-1slide40.jpg | GRAPHIC | 122198
16 |  | brhc10030727_ex99-1slide41.jpg | GRAPHIC | 126453
17 |  | brhc10030727_ex99-1slide42.jpg | GRAPHIC | 40180
18 |  | brhc10030727_ex99-1slide43.jpg | GRAPHIC | 139831
19 |  | brhc10030727_ex99-1slide44.jpg | GRAPHIC | 99148
20 |  | brhc10030727_ex99-1slide45.jpg | GRAPHIC | 111576
21 |  | brhc10030727_ex99-1slide46.jpg | GRAPHIC | 142655
22 |  | brhc10030727_ex99-1slide47.jpg | GRAPHIC | 132940
23 |  | brhc10030727_ex99-1slide48.jpg | GRAPHIC | 39942
24 |  | brhc10030727_ex99-1slide49.jpg | GRAPHIC | 123311
25 |  | brhc10030727_ex99-1slide50.jpg | GRAPHIC | 40310
26 |  | brhc10030727_ex99-1slide51.jpg | GRAPHIC | 140451
27 |  | brhc10030727_ex99-1slide52.jpg | GRAPHIC | 102702
28 |  | brhc10030727_ex99-1slide53.jpg | GRAPHIC | 41118
29 |  | brhc10030727_ex99-1slide54.jpg | GRAPHIC | 116391
30 |  | brhc10030727_ex99-1slide55.jpg | GRAPHIC | 125198
31 |  | brhc10030727_ex99-1slide56.jpg | GRAPHIC | 122841
32 |  | brhc10030727_ex99-1slide57.jpg | GRAPHIC | 126636
33 |  | brhc10030727_ex99-1slide58.jpg | GRAPHIC | 136990
34 |  | brhc10030727_ex99-1slide59.jpg | GRAPHIC | 129813
35 |  | brhc10030727_ex99-1slide60.jpg | GRAPHIC | 121715
| Complete submission text file | 0001140361-21-037501.txt |  | 5101819

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | btx-20211111.xsd | EX-101.SCH | 3929
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | btx-20211111_lab.xml | EX-101.LAB | 22544
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | btx-20211111_pre.xml | EX-101.PRE | 16047
36 | EXTRACTED XBRL INSTANCE DOCUMENT | brhc10030727_8k_htm.xml | XML | 4246

Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 211398916
SIC: 2834 Pharmaceutical Preparations